SAN ANTONIO -- Women with larger, genomically high-risk breast cancers had significantly lower risk of distant metastasis with chemotherapy that included an anthracycline, a new analysis of a ...

The study, published in JACC: CardioOncology, demonstrates that treatment with the SGLT2 inhibitor empagliflozin can mitigate ...

Considering taking supplements to treat anthracycline cardiotoxicity? Below is a list of common natural remedies used to treat or reduce the symptoms of anthracycline cardiotoxicity. Follow the ...

Astrazeneca has identified anthracycline compounds and antibody-drug conjugates consisting of an antibody covalently bound to anthracycline derivatives reported to be useful for the treatment of ...

And the benefits were found to be particularly promising for breast cancer patients receiving a common chemotherapy type called anthracycline chemotherapy, which can affect heart health.

CNS Pharmaceuticals (NASDAQ: CNSP) announced results from its Phase 2 clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma ...

The benefits were found to be particularly promising for breast cancer patients receiving a common chemotherapy type called anthracycline chemotherapy, which can affect heart health. Lead researcher ...

The Company's lead program, Berubicin, is an anthracycline with demonstratable efficacy in Phase 1, and as previously announced in April 2024, completed enrollment with 252 patients in its ...